doiSerbia

Chronic lymphocytic leukaemia: An immunobiology approach

Kostareli Efterpi (Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece)
Smilevska Tatjana (Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece)
Stamatopoulos Kostas (Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece)
Kouvatsi Anastasia (Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece)
Anagnostopoulos Achilles (Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece)

B cell chronic lymphocytic leukaemia (CLL) is the most common adult leukaemia that follows an extremely variable clinical course. Several important prognostic parameters defining pathogenic and clinical subgroups of CLL have been identified and validated recently. The biological significance of immunoglobulin (Ig) heavy chain variable region gene (IgHV) mutational status and associated ZAP-70 over-expression, CD38 and chromosomal aberrations have enabled to identify patients at high risk for early disease progression and inferior survival. Moreover, studies of the B cell antigen receptor (BCR) structure and receptor signaling have been most helpful in revealing some new aspects of the biology of this disease. In particular, the analysis of IG genes has revealed that the expressed IgHV/IgKV/IgLV gene repertoires of CLL cells differ from those of normal B cells. A further unique feature of the CLL IG repertoire is the existence of subsets of cases with "stereotyped" BCRs. Accumulating molecular and phenotypic data support the notion that CLL development and evolution is not a simple scholastic event and strongly indicates a role for antigen in driving the cell of origin for at least some subsets of CLL cases.

Keywords: chronic lymphocytic leukaemia, clinical characterististics, molecular genetic aspects, immunoglobulin repertoire